Amgen's Aimovig Riding High With Strong Prescriber, Payer Acceptance

New commercial head Murdo Gordon described Aimovig as one of the best launches he's ever seen and said growth should continue – though moderate – based on prescriber experience and rapid transitions from free drug to reimbursed prescriptions.